About
ProSciento provides comprehensive scientific and operational expertise in the design and management of all facets of clinical drug and device development for diabetes. ProSciento’s services and client-specific programs are initiated from a deep scientific expertise in disease pathophysiology, drug classes, methodologies and nearly two decades of experience in clinical research, development and regulatory strategies exclusively for metabolic diseases.
Recommended Materials
Articles
A randomized, single ascending dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel insulin dimer
Articles
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline
Textbooks
Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development
Related Solutions
Specialized Methods
